News

Filter

Current filters:

None

251 to 260 of 97576 results

Ferrer licenses Canadian rights for ozenoxacin to Cipher Pharma

07-01-2015

Privately-held Spanish pharmaceutical company Ferrer says it has licensed commercialization rights for…

CanadaCipher PharmaceuticalsDermatologicalsFerrerLicensingOzenoxacinPharmaceutical

Indian government plans to establish dynamic and balanced IPR policy

Indian government plans to establish dynamic and balanced IPR policy

07-01-2015

Even as US President Barack Obama is slated to be the chief guest at India's Republic Day Parade on January…

IndiaPatentsPharmaceuticalPoliticsUSA

Aveo Oncology appoints Michael Bailey as president

Aveo Oncology appoints Michael Bailey as president

07-01-2015

Aveo Oncology has appointed Michael Bailey as president, chief executive and director.

AVEO OncologyBoardroomOncologyPharmaceuticalUSA

FDA grants Soligenix Fast Track status for SGX301

FDA grants Soligenix Fast Track status for SGX301

07-01-2015

Late-stage biopharma company Soligenix has said that its SGX301 (synthetic hypericin) development program…

OncologyPharmaceuticalRegulationSGX301SoligenixUSA

Shield Therapeutics' MAA for Ferracru accepted for review by EMA

Shield Therapeutics' MAA for Ferracru accepted for review by EMA

07-01-2015

Independent UK pharma company Shield Therapeutics has received acceptance for review of the Marketing…

FerracruHematologyPharmaceuticalRegulationShield TherapeuticsUK

Pfizer enters race to develop Duchenne muscular dystrophy therapy

Pfizer enters race to develop Duchenne muscular dystrophy therapy

07-01-2015

US pharma giant Pfizer is the latest company to enter the race to develop a therapy for Duchenne muscular…

GeneticsPF-06252616PfizerPharmaceuticalResearchUSA

Sobi extends distribution agreement with Exelixis for Cometriq

Sobi extends distribution agreement with Exelixis for Cometriq

07-01-2015

Swedish Orphan Biovitrum today announced that its agreement with Exelixis has been restructured and extended…

BiotechnologyCometriqEuropeExelixisMarkets & MarketingOncologySobi

CHMP recommends approval of Newron/Zambon's Xadago for Parkinson's disease

CHMP recommends approval of Newron/Zambon's Xadago for Parkinson's disease

07-01-2015

Italy-based Newron Pharmaceuticals and its partner Zambon have received a recommendation from the Euroean…

ItalyNeurologicalNewron PharmaceuticalsPharmaceuticalRegulationXadagoZambon

ThromboGenics NV appoints Dominique Vanfleteren as chief financial officer

ThromboGenics NV appoints Dominique Vanfleteren as chief financial officer

07-01-2015

Ophthalmic specialist ThromboGenics NV has appointed Dominique Vanfleteren as chief financial officer.

BelgiumBoardroomOphthalmicsPharmaceuticalThromboGenics

251 to 260 of 97576 results

Back to top